Amgen (AMGN) PT Raised to $350 at Cantor Fitzgerald

February 4, 2026 9:59 AM EST Send to a Friend
Cantor Fitzgerald analyst Carter Gould raised the price target on Amgen (NASDAQ: AMGN) to $350.00 (from $315.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login